This inventor holds 3 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1987-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Izumiohtsu, JP (1987)
- Toda, JP (2002 - 2006)
Company Filing History:
Years Active: 1987-2006
Title: The Innovations of Tomoyasu Taniguchi
Introduction
Tomoyasu Taniguchi is a notable inventor based in Toda, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of peroxisome proliferator-activated receptors (PPARs). With a total of 3 patents to his name, Taniguchi's work has implications for drug discovery and development.
Latest Patents
Taniguchi's latest patents focus on methods for identifying or screening agonists and antagonists to PPAR. One of his patents describes a method that involves allowing a test cell and a substance to coexist. It detects changes in the ligand-dependent interaction between the PPAR and a coactivator in the test cells. This is achieved by measuring the expression of a reporter gene as an index. This innovative approach has the potential to advance the understanding of PPAR-related pathways.
Career Highlights
Taniguchi is currently associated with Tanabe Seiyaku Company, Limited, where he continues to push the boundaries of scientific research. His work has been instrumental in developing new therapeutic strategies that target metabolic diseases.
Collaborations
Throughout his career, Taniguchi has collaborated with esteemed colleagues, including Junko Mizukami and Saburo Komatsubara. These partnerships have fostered a collaborative environment that enhances the research output and innovation at Tanabe Seiyaku.
Conclusion
Tomoyasu Taniguchi's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His innovative methods for screening PPAR agonists and antagonists pave the way for future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile